Adaptive image-guided radiotherapy in MIBC shows low toxicity and good outcomes

Описание к видео Adaptive image-guided radiotherapy in MIBC shows low toxicity and good outcomes

Prof Robert Huddart speaks to ecancer about late toxicity and cancer outcomes of a randomised phase II trial of adaptive image-guided radiotherapy in muscle-invasive bladder cancer.

The study aimed to define a feasible, safe schedule for muscle-invasive bladder cancer using the plan of the day adaptive image-guided RT and tumour boost dose escalation.

The team found that the toxicity was low in all treatment groups. Local control for image-guided (chemo) RT was also good.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

Комментарии

Информация по комментариям в разработке

Похожие видео